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Mice infected with Schistosoma  mansoni acquire a  partial  resistance to subsequent 
challenge infection  (1).  A  number of studies  have suggested  that  this  immunity is 
directed in large part against the early schistosomulum during the period immediately 
after its entry into the host  (1-3). For example, it has been shown that within 24 h 
after  intravenous  injection  into  mice,  newly  transformed  schistosomula  lose  their 
susceptibility to rejection by passively transferred antibody (1). 
An intriguing mechanism for explaining the resistance of older parasites to immune 
killing  was  proposed  by Smithers  et  al.  (4).  These investigators  demonstrated  the 
presence of substances  of host  origin on  the  integument  of adult  schistosomes and 
speculated that host molecules might promote the survival of the parasites by masking 
target antigens on the worm surface. In support of their hypothesis, a correlation was 
demonstrated  between the acquisition  of host  molecules by schistosomula  and  the 
inability of the  larvae to bind  antibodies  directed against  parasite  antigens  (5,  6). 
Nevertheless, no direct evidence has been obtained supporting a  protective role for 
host molecules, and other changes in the integument could account for the ability of 
older parasites to survive in immune hosts. 
In this paper, a new approach for analyzing the mechanisms responsible for the loss 
in  susceptibility  to  immune  damage  undergone  by  developing  schistosomula  is 
introduced. Parasites were surface labeled with haptenic target groups and tested at 
various stages of their development for their ability to be killed by hapten-specific 
effector mechanisms. Immune damage to the hapten-conjugated worms was assayed 
by measuring  the survival of these parasites  after either intravenous injection into 
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hapten-immunized mice or in vitro culture with anti-hapten antibody in combination 
with  either complement  (C) 1 or human  eosinophils.  The above are adaptations  of 
assays of antibody-dependent damage to schistosomula, which have been extensively 
utilized by workers in the field (1,  7). The experiments were designed for testing the 
specific hypothesis that  the  increased  resistance of older  schistosomula  to  immune 
attack is caused by an intrinsic change in the larvae which occurs independently of 
the masking of parasite antigens by the host molecules. Thus, if the absorption of host 
molecules  is  the  principal  mechanism  by  which  lung-stage  schistosomula  escape 
antibody-dependent damage, then it should be possible to bypass the host molecule 
disguise  of these  parasites by superimposing  nonparasite  haptenic  groups  on  their 
surface,  thereby  rendering  them  susceptible  to  immune  damage  by  antihapten- 
directed  antibodies.  Alternatively,  if  hapten-conjugated  lung  worms  behave  like 
unlabeled  lung worms and are found to be less susceptible than early stage schisto- 
somula to  immune killing,  it  would  strongly suggest  that  a  change  in  the parasite 
surface unrelated to the masking of parasite antigens by host molecules is responsible 
for the resistance of the larvae to immune attack. 
Trinitrophenyl (TNP) groups were chosen as the haptenic moieties for the surface 
labeling  of schistosomula  in  these  experiments.  This  hapten  has  been  used  as  a 
schistosomulum surface label  for the  investigation of helper T  cell  responses to the 
larvae (8-10). The labeling procedure utilized in that work killed the majority of the 
parasites (10), and therefore was not suitable for the present study. Described below 
is a modified TNP labeling procedure, which results in only a minimal loss in viability 
of the parasites. Using this technique, we have obtained evidence which suggests that 
an intrinsic change in the tegument of schistosomula plays a  role in the resistance of 
older larvae to immune damage. 
Materials and Methods 
Laboratory  Hosts.  Female  DBA  mice  (6-  to  9-wk-old)  were  obtained  from The Jackson 
Laboratory, Bar Harbor, Maine. Outbred female CFt mice (18-20 g) and male CD rats (175- 
250 g) were supplied by Charles River Breeding Laboratories (Wilmington, Mass.). 
Parasite.  Schistosoma mansoni (Puerto Rican strain) is routinely maintained in our laboratory 
by passage through Biomphalaria  glabrata snails and outbred CFt mice (11). Skin-stage  (3-h-old) 
schistosomula were prepared in vitro from cercariae using an adaptation of the skin penetration 
method (12, 13). Lung-stage (5-d-old) schistosomula were prepared from mice infected  subcu- 
taneously with 2,000-3,000  cercariae, or injected  intravenously with an equivalent number of 
skin-stage  schistosomula  (14). 4-6  d  after  infection,  the  mice  were  sacrificed,  and  viable 
schistosomula  were recovered and purified from chopped lung tissue according to techniques 
which  have been already described  (2,  14,  15). Both the subcutaneous and the intravenous 
routes of infection resulted in a 15-30% recovery of lung-stage parasites and were found to yield 
organisms with similar properties in the assays used in this paper. 
Surface Labeling  of Schistosomula.  Parasites were coupled with TNP using a modified version 
of a procedure previously described  (9,  10). 2,4,6-trinitrobenzenesulfonic  acid  (TNBS)  (ICN 
Nutritional  Biochemicals,  Cleveland, Ohio)  was dissolved  in  Hanks' balanced salt  solution 
(HBSS) and the solution adjusted to pH 7.0-7.2 with NaOH. Schistosomula were washed three 
times in HBSS by centrifugation (10 s, 400 g) and resuspended to a concentration of 1,500/ml. 
1 vol of the parasite suspension  was incubated at 37°C with an equal volume of the TNBS 
solution  in a tube covered with foil. The mixture was allowed to react either for 15 rain using 
1 Abbreviations used in this paper: BGG, bovine gamma globulin; C, complement; FCS, fetal calf serum; 
FITC, conjugated with fluorescein isothiocyanate; HBSS, Hanks' balanced salt solution; HI, heat-inacti- 
vated; MEM/H,  Eagle's minimum essential medium buffered with Hepes; TNBS, 2,4,6-trinitrobenzene- 
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2 mM TNBS, or for 45 s using higher concentrations of TNBS (1.56-25 mM).  (The shorter 
incubation time was  usually found to  result  in a  lower loss  in parasite  viability and  was 
therefore used throughout this study unless otherwise indicated.) The reaction was stopped by 
adding an excess of Hepes-buffered Eagle's minimum essential medium (MEM) (Grand Island 
Biological Co., Grand Island, N. Y.), containing 100 U/ml penicillin, 100 btg/ml streptomycin, 
1% L-glutamine, and 20% fetal calf serum (FCS) (MEM/H-20% FCS) to the tube. The hapten- 
coupled parasites were then washed three times with MEM/H-10% FCS and two additional 
times with sterile medium for in vitro culture, or resuspended in MEM-2% FCS for injection 
into mice. 
Induction of Anti-TNP Antibodies and Preparation of Rat Anti-Schistosome Sera.  Anti-TNP antibod- 
ies  were  raised  in  New  Zealand White  rabbits  by  intramuscular injection with  3  mg  of 
TNPsgbovine gamma globulin (BGG)  (16) emulsified in complete Freund's adjuvant (Difco 
Laboratories, Detroit, Mich.)  followed  by three boosts at  2-wk  intervals with antigen at  the 
same dose in incomplete Freund's adjuvant. CFx mice were immunized subcutaneously with 
TNP-BGG or unsubstituted BGG in Freund's adjuvant using a similar protocol employing 0.2 
mg of antigen/injection (17). Sera from mice and rabbits actively immunized against TNP- 
BGG were found to contain average reciprocal hemagglutination  titers (measured against TNP 
8  9  13  horse or sheep  erythrocytes) of 2  and 2 -2  , respectively (18). Rat anti-schistosome sera was 
obtained from CD rats 8 wk after percutaneous infection with  1,500 cereariae each  (19). All 
antibody pools were heat-inactivated (HI) for 30 min at 56°C before use. 
In  Vivo Assay of Immunity.  Immunity to challenge infection was measured by determining 
the recovery of adult worms from the hepatic portal system 6 wk later, according to procedures 
previously  described (19). The level of immunity  to challenge infection was calculated according 
to the formula: 
C-E 
percent immunity =  ×  100, 
where  [; equals the  mean recovery from experimental (TNP-BGG-immunized) and  C,  the 
mean recovery from control (BGG-immunized) mice (seven to nine per group). The Student's 
t  test  was  used to  analyze the  statistical significance of the  differences in worm  recoveries 
between the two groups. 
In  Vitro Assay of Damage to Schistosomula by Antibody Plus C.  Antibody-dependent  C-mediated 
damage to schistosomula was assayed in U-bottom microtiter wells using a modified version of 
a procedure described elsewhere  (20). The duplicate assay wells contained 0.05 ml of schisto- 
somula (100/well), 0.05 ml of diluted immune serum or HI normal rabbit (Gibco Diagnostics, 
GibcoInvenex Div., Chagrin Falls, Ohio) or rat serum, plus 0.1 ml of diluted guinea pig C or 
HI C, or medium (MEM/H-10% FCS) alone. After incubation for  18 or 63 h  at 37°C, the 
organisms were  transferred  to  slides  previously coated  with  0.1%  toluidine blue  and  the 
percentage of dead larvae determined by microscopic examination (20, 21). 
In  Vitro Assay of Damage to Schistosomula by Antibody Plus Eosmophils.  Antibody-dependent 
eosinophil-mediated damage to schistosomula was assayed using techniques similar to  that 
above except that purified human eosinophils (0.1 ml) were substituted for guinea pig C and 
the cultures incubated for 18 or 36 h (20). The eosinophils were purified from the blood of one 
human volunteer by discontinuous metrizamide gradient centrifugation and ranged in purity 
from 83 to 96%. The percentage of dead larvae as well  as  the percentage of larvae with >5 
adherent eosinophils were determined at the end of the culture period (20). In some experiments, 
the cell-parasite reactions were stopped by the addition of Karnovsky's fixative (22), and the 
percentage of adherent eosinophils which were degranulated scored by microscopic examination 
(×  1,000) with Nomarski optics on 10 worms/sample. 
Quantitative Immunofluorescence.  The amount of anti-TNP antibody bound to skin- and lung- 
stage schistosomula was compared by means of quantitative immunofluorescence.  This method 
was  chosen instead of radioimmunoassay because it  measures individual worms and conse- 
quently avoids potential inaccuracies as a result of the presence of contaminating host tissue in 
lung worm preparations to which anti-TNP antibodies might also bind. That the measurements 
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been  confirmed  in  a  separate  series of experiments  involving the  reaction  of lectin with  the 
larval membrane (J. Samuelson. Personal communication.). 
In  the  procedure,  schistosomula  were  incubated  with  either  rabbit  anti-TNP  sera  (1:5), 
normal rabbit sera (1:5), or medium alone, washed and then reacted with fluorescein-conjugated 
(FITC) goat antirabbit IgG (1:10) (N. L. Cappel Laboratories Inc., Cochranville, Pa.) according 
to the indirect immunofluoreseence protocol already described (11). The amount of fluorescence 
emitted/200/~m 2 area of a worm was measured in relative units by a  Leitz MPV-2 photometer 
attached  to a  Leitz Orthoplan  microscope equipped with a  Ploem illuminator for fluorescein 
(E.  Leitz,  Rockleigh,  N. J.).  Approximately  20  readings  (1  reading/worm)  were  taken  per 
sample  and  averaged.  Specific fluorescence was  determined  by  subtracting  the  mean  back- 
ground values (TNP sehistosomula plus normal rabbit  serum plus FITC goat antirabbit  IgG) 
from the mean experimental values (TNP schistosomula plus rabbit  anti-TNP antibody plus 
FITC goat antirabbit  IgG). 
Results 
Viability of TNP-labeled Schistosomula.  The viability of TNP-eonjugated schistosom- 
ula was analyzed by either morphological examination  18-36 h after culture or portal 
recovery of these parasites 6 wk after intravenous injection. In general, the survival of 
TNP schistosomula both in vivo and in vitro was the same or slightly lower than that 
of uncoupled parasites.  Thus,  the portal  recovery  of TNP  skin-stage  schistosomula 
from  unimmunized  mice  was  -35%  vs.  a  recovery  value  of  ~36%  for  uncoupled 
larvae.  Similarly,  after  36  h  of culture,  TNP-conjugated  and  unconjugated  larvae 
exhibited  mortality  levels  ranging from  5  to  20%  and  from  3  to  20%,  respectively. 
Although these  mortality  values  varied  somewhat  from  experiment  to experiment, 
lung-stage schistosomula, both coupled and uncoupled, consistently exhibited a lower 
loss in viability than skin-stage schistosomula. 
To  test  for  the  possibility  that  the  TNP  labeling  procedure  induced  sublethal 
damage  to the parasites  which  renders  them  more  sensitive  to immune  killing,  the 
susceptibility of labeled and unlabeled schistosomula to damage by rat anti-schisto- 
some  antibody and C  was  compared.  As indicated  in Table  I, TNP  schistosomula, 
TAnLE  I 
Susceptibility of TNP Schistosomula to Killing by Rat Anti-Schzstosome 
Antibody Plus C 
Percent (mean)  dead schistosomula  Concentration  Incubation  of TNBS used 
time  for labeling  C +  ab*  C -  ab:]:  ([~C +- ab]ab])- 
h  mM  % specific kill 
18  0  43.0  10.1  32.9 
6.25  38.4  9.0  29.4 
12.5  36.2  12.4  23.8 
25.0  45.5  14.3  31.2 
63  0  76.9  19.5  57.4 
6.25  64.6  10.8  53.8 
12.5  63.4  19.4  44.0 
25.0  73.8  23.2  50.6 
* Reaction mixtures contained 12.5% rat anti-schistosome 
pig sera as a source of C. 
~- Reaction mixtures contained 12.5% normal rat sera and 
sera and 25'7~ guinea 
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prepared  with  TNBS  concentrations  ranging  from  6.25  to  25  mM,  exhibited  a 
sensitivity to anti-schistosome antibody-dependent C-mediated killing which did not 
differ significantly from that of unlabeled worms, even in cultures maintained for as 
long as 63  h.  Therefore, as judged  by this  criterion,  reaction  with  TNBS  does not 
predispose the larval integument to immune damage. 
Relative Measurement of Anti-TNP Antibody Bound to  TNP Schistosomula.  Before com- 
paring the susceptibility of labeled skin- and  lung-stage worms to damage by anti- 
TNP effector mechanisms, it was necessary to show that the amount of anti-hapten 
antibody bound  to these TNP-conjugated  larval stages was comparable. The tech- 
nique of quantitative immunofluorescence was used for these measurements. As shown 
in Table II, lung-stage sehistosomula labeled  for 45 s with  25  mM TNBS or for  15 
rain with  1 mM TNBS, were found to emit either the same or a statistically greater 
amount  of immunofluorescence  than  skin-stage  worms.  These  results  suggest  that 
lung-stage  schistosomula  bind  as  much  if not  more  anti-TNP  antibody  on  their 
surface as do skin-stage schistosomula.  In other experiments  (not shown), TNP 3-h- 
old and TNP 5-old schistosomula were found after 36 h of culture to retain 96.4 and 
81.2% of their TNP groups, respectively, as measured by microfluorimetry. Similarly, 
no significant loss of bound anti-TNP antibody was observed from either larval stage 
during the same culture period. 
Susceptibility of TNP Schistosomula to Rejection in  TNP-immunized Mice.  Mice actively 
immunized  against  either TNP-BGG or  BGG were  challenged  intravenously  with 
either  TNP-labeled  skin-  or  lung-stage  schistosomula.  Recovery  of the  challenge 
infection was measured 6 wk later at the adult stage. As shown in Fig.  1 A, TNP 3-h- 
old worms were readily rejected by TNP-BGG immunized mice, as evidenced by a 
96% reduction  (P <  0.001)  in the recovery of the parasites from TNP-BGG vs. BGG- 
immunized  mice.  In contrast,  a  much  smaller percentage  (46%)  (P <  0.02)  of the 
TNP 5-d-old schistosomula were rejected by the same TNP-immunized animals (Fig. 
1 B), indicating that older worms are partially susceptible to hapten-specific killing, 
but clearly far less so than worms newly transformed from cercariae. 
Susceptibility of TNP Schistosomula to Anti-TNP Antibody-dependent C-mediated Killing In 
Vitro.  It has been previously shown that newly transformed schistosomula are readily 
TABLE  II 
Quantitation of TNP Groups by Microfluorimetry 
Conditions  Specific fluorescence (in relative units)* 
for TNP cou-  Experiment  3-h schisto-  5-d schisto- 
piing  somula  somula  P values 
A:~  1  49.8  72.3  <0.05 
2  53.7  101.9  <0.001 
B§  1  68.9  63.1  NSII 
2  80.5  79,5  NS 
* See Materials and Methods. Note: unlabeled parasites plus anti-TNP anti- 
body  plus  FITC  goat  antirabbit  IgG  (control  for  nonspecific binding of 
antibody)  gave  fluorescence  readings  similar  to  those  obtained  for  the 
background group (8-27). 
~: Parasites surface labeled for 15 rain with I mM TNBS. 
§ Parasites surface labeled for 45 s with 25 mM TNBS. 
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Ft~.  t.  Rejection of TNP schistosomula by CFI mice actively immunized  against TNP. 3-h-old 
schistosomula (150/mouse)  (A) and 5-d-old schistosomula (110/mouse)  (B) were surface labeled 
with 1 mM TNBS for 15 min and used to challenge mice actively immunized against either TNP- 
BGG or BGG. Percent recovery refers to the percent of challenge schistosomula recovered as adult 
worms. 
~  25 
25  625  1.56  25  6.25  1.56 
FIG.  2,  Antibody-dependent C-mediated killing of TNP scbistosomula. 3-h-old  (A)  and 5-d-old 
(B) schistosomula, surface labeled with either 25, 6.25, or 1.56 mM TNBS (45 s), were cultured with 
either rabbit anti-TNP antibody (12.5%) plus (2 (25%) (~), normal  rabbit serum plus C  (~l), or 
medium alone ('). Parasite killing was assayed after 18 h of cuhure. 
killed in vitro by antischistosome antibody plus C  (7,  13). The susceptibility of TNP 
skin- and lung-stage schistosomula to TNP-specific killing by this C-mediated mech- 
anism was compared in the following experiment. Schistosomula, labeled with differ- 
ent  concentrations  of TNBS  (25,  6.25,  and  1.56  mM),  were  exposed  to  anti-TNP 
antibody plus C  or control media and examined after  18 h ofcuhure. TNP skin-stage 
schistosomula were found to be extremely susceptible to C-mediated killing (Fig. 2). 
Furthermore, the level of killing was highly dependent on the concentration of TNBS 
used for labeling the larvae. In contrast, TNP lung-stage schistosomula were essentially 
refractory to C-mediated damage, even when  labeled with the highest concentration 
(i.e., 25 raM) of TNBS tested. 
To make certain that  the insusceptibility of lung worms to complement-mediated 
killing was not caused by insufficient quantities of effector elements, cultures were set 
up in which the concentration of antibody and/or C  was doubled. As shown  in Fig. 
3,  3-h-old schistosomula,  labeled with  either  12.5  or  25  mM  TNBS  and  incubated 
with different dilutions ofC  (l& or l~) and/or anti-TNP antibody (¼ or l/s), were in all 
cases readily killed and most effectively at the higher concentrations of C. In contrast, 
lung-stage  schistosomu!a remained  almost  totally resistant  to  TNP-specific  killing, 
even  when  the  concentration  of C  was  increased  to  50%  and  the  concentration  of 
antibody to 25%. 
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Flo.  3.  Effect  of varying the concentration of  antibody and C on the killing ofTNP sehistosomula. 
25 mM (A) or 12.5 mM (B) TNBS was used to surface label 3-h-old (a bars) and 5-d-old (b bars) 
schistosomula. Parasites were cultured for 18 h with either rabbit anti-TNP antibody plus C (l~l), 
normal rabbit serum plus C (BI), at the dilutions indicated, or medium alone (l). Mortality was 
assessed as in Fig. 2. 
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FiG. 4.  Antibody-dependent eosinophil-mediated killing ofTNP schistosomula. 3-h-old (A) and 5- 
d-old (B) schistosomula, surface labeled with either 25, 6.25, or 1.56 mM TNBS were cultured with 
either rabbit  anti-TNP  antibody  (12.5%) plus human  eosinophils (effector cell:parasite target  = 
2,000:1) (B), normal rabbit serum (12.5%) plus eosinophils (Ira), or medium alone (1).  Parasite 
mortality was determined after 36 h of incubation. 
Killing  In  Vitro.  Another  well-studied  example  of an  antibody-dependent  effector 
mechanism which kills schistosomula in vitro, is that mediated by human eosinophils 
(7, 20). In an adaptation of this assay to haptenated schistosomula, skin-stage parasites 
were found to be readily killed in vitro by anti-TNP antibodies and eosinophils, the 
level  of killing  being dependent  on  the concentration  of TNBS  (25,  6.25,  and  1.65 
mM) used for labeling (Fig. 4 A). In contrast, lung-stage schistosomula were shown to 
be highly resistant  to killing, even when labeled with 25 mM TNBS (Fig. 4 B). 
In this experiment, the adherence of effector cells to the larvae was also quantitated. 
As indicated in Fig. 5, after 36 h of cuhure, the adherence of eosinophils to lung-stage 
schistosomula was found to be greater than the adherence to skin-stage schistosomula 
at  each  of the  three  concentrations  of TNBS  used  for  labeling.  This  observation 
indicates that the resistance of the lung worms to eosinophil mediated damage is not 
a  result of a  failure in the binding of effector cells to the parasites. 
To confirm that  the  failure  of lung-stage  schistosomula  to be killed  by antibody 
and effector cells was not caused by a  deficiency of effector elements in the cultures, 
the concentration ofeosinophils and/or anti-TNP antibody was doubled in the assay. 
As shown in Fig. 6, TNP lung-stage schistosomula remained resistant  to killing, even 
when the effector cell/target  ratio was increased  to 4,000/1  and anti-TNP  antibody 
increased to 25% in the cultures. It has been argued that temperature-dependent  cell 48  SUSCEPTIBILITY  OF  SCHISTOSOMULA  TO  IMMUNE  KILLING 
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Fro.  5.  Antibody-dependent adherence of eosinophils to TNP schistosomula. The adherence of 
effector cells to TNP 3-h-old (A) and 5-d-old (B) schistosomula as determined for the experiment 
depicted in Fig. 4. W, TNP schistosomula incubated with anti-TNP antibody plus eosinophils. VA, 
TNP schistosomula incubated with normal rabbit serum plus eosinophils. 
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Fro.  6.  Effect of varying the concentration of anti-TNP  antibody  (Ab)  and eosinophils on  the 
killing of TNP schistosomula. 3-h-old (a bars) and 5-d-old (b bars) schistosomula, surface labeled 
with 25  mM TNBS,  were incubated with either rabbit  anti-TNP  antibody  (diluted  1/4=25% or 
%=12.5%)  plus eosinophils (effector [Eft.] celhtarget--4,000:1 or 2,000:1)  (1~), normal rabbit serum 
plus cells (11), or medium alone (11). Parasite mortality was assayed after 36 h incubation. 
degranulation is a crucial step in the antibody-dependent killing of schistosomula by 
eosinophils (21, 23). To confirm that the insusceptibility of TNP lung-stage schisto- 
somula to killing by eosinophils was not caused by the failure of the cells to degranulate 
on the parasite surface, the percentage of degranulated eosinophils adhering to skin- 
vs. lung-stage TNP-labeled worm targets was compared. In two different experiments 
(Table III), the percentage of degranulation of cells on lung-stage worms was found 
not to differ significantly from the values determined for skin-stage larvae. In addition, 
both  eosinophil degranulation and  parasite  killing were shown  to be  temperature 
dependent.  However, in the case of lung worms, eosinophil degranulation was not 
accompanied by parasite killing. 
Discussion 
Previous studies have suggested that the newly transformed schistosomulum is a 
major target in the rejection of challenge infections by mice with acquired resistance 
to S.  mansoni  (1-3). That the susceptibility of schistosome larvae to immune attack is 
age dependent  has also been  suggested by in  vitro studies in which schistosomula 
after overnight i=ulture were shown to become resistant to killing mediated by either 
antibody and C  (24) or antibody plus eosinophils.  2 
2 Dessein, A., J. C. Samuelson, A. E. Butterworth, M. E. Hogan, B. A. Sherry, M. A. Vadas, and J. R. 
David.  1979. Immunologic studies on  Schistosoma raansoni larvae.  I.  Loss of susceptibility to antibody or 
complement-dependent eosinophil attack by schistosomula cultured  in  medium  free of macromolecules. 
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TABLE III 
Degranulation of Eosinophils on the Surface of TNP Schistosomula 
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Percent degranulated eosino-  Percent (mean) lar-  Percent (mean) spe- 
vae with >5 adher-  cific kill~ ([cells +  Experi-  TNP lar-  phils adhering to larvae*  ent eosinophils*  ab] -  [cells -  ab])  ment  vae 
37°C  4°C  37°C  4°C  37°C  4°C 
mean .4- SD 
1  Skin  52.7 ±  12.8  3.9 ±  7.8  88.8  100  80.5  ND§ 
53.9 ± 21.7  6.1 ± 3.6 
Lung  61.6 ±  16.7  5.5 ± 4.9  100  100  15.2  ND 
65.1 ±  15.3  6.1 ± 3.5 
2  Skin  70.0 ±  14.9  3.6 ± 4.1  100  95  87.8  0 
65.8 ±  14.4  4.7 ± 4.5 
Lung  74.6 ±  7.6  3.0 ± 3.4  100  100  11.3  1.8 
72.2 ±  14.1  3.2 ± 3.5 
* Results from duplicate samples were scored after 18 h of incubation. 
:[: Samples were assayed after 36 h of incubation. 
§ ND, not done. 
In the present study, we have compared the susceptibility of developing schistosom- 
ula to immune killing in a  model system employing TNP  target antigens and anti- 
TNP antibodies. The major conclusion of this report is that TNP-coupled lung-stage 
(5-d-old) schistosomula are far less susceptible than TNP-labeled skin-stage (3-h-old) 
schistosomula to killing by anti-TNP effector mechanisms both in vivo (Fig.  1) and in 
vitro  (Figs. 2-4  and  6).  This  difference was  observed even  though  TNP  lung-stage 
larvae appeared  to  bind  the same  amount  or more  anti-TNP  antibody than  TNP 
skin-stage larvae before culture  (Table  II)  and  were  found  to  retain  most  of their 
TNP as well as bound anti-TNP antibody after 36 h  of culture. 
In our in vivo experiments, TNP skin worms were shown to be extremely susceptible, 
whereas  TNP  lung-stage  worms  were  found  to  be  partially  (although  far  less) 
susceptible to immune killing in TNP-immunized mice (Fig.  1). Rejection of schisto- 
somula  in  these  animals  is  likely  to  involve  an  antibody-dependent  mechanism, 
because sera from the mice were found to contain high titers of anti-TNP antibodies 
and because in separate studies  (G. Moser and A. Sher.  Unpublished observations.) 
we have been able to transfer significant immunity against TNP  schistosomula with 
as little as 0.015  ml of mouse anti-TNP serum per recipient. 
The susceptibility of TNP larvae to antibody-dependent damage was tested directly 
in  our  in  vitro  experiments.  In  contrast  with  TNP  skin-stage schistosomula,  TNP 
lung-stage  schistosomula  were  found  to  be  highly  resistant  to  rabbit  anti-TNP 
antibody-dependent damage mediated by either C  or eosinophils. That  the insuscep- 
tibility of lung worms to TNP-specific killing mechanisms in vitro was not a  result of 
a  deficiency in the number of TNP target antigens on the surface of the parasite or to 
an insufficient concentration of effector elements in the cultures was demonstrated by 
showing that doubling the TNBS used in labeling or the concentrations of antibody, 
C, or eosinophils did not significantly alter the killing of the parasites (Figs. 3 and 6). 
It could be argued, however, that the failure of lung worms to be killed by antibody 
plus C  is caused by the inactivation of C  components by the parasite during culture. 
Although  this  possibility cannot  be  ruled  out,  it  seems  unlikely  in  light  of recent 50  SUSCEPTIBILITY OF SCHISTOSOMULA TO IMMUNE KILLING 
results, where it was shown that during a 45-min incubation, lung-stage schistosomula 
deplete neither C3 nor Factor B from human serum.  3 Similarly, it is improbable that 
the  insusceptibility  of lung-stage  parasites  to  killing  by  anti-TNP  antibody  plus 
eosinophils was a  result of the blocking of the reaction by the parasite, because the 
adherence of eosinophils to the lung worms was in fact greater than that to skin-stage 
schistosomula (Fig. 5) and the degranulation of these effector cells was quantitatively 
comparable on both parasite targets (Table III). 
On  the basis of the above evidence, we propose that  the  insusceptibility of lung 
worms to immune damage must be caused at least in part by an intrinsic change in 
the larval surface which is independent of the masking of parasite antigens by host 
molecules. Our results, however, do not exclude a possible function for host molecules 
in  blocking  the  interaction of toxic effector elements  (e.g.,  C  activation  products, 
eosinophil major basic protein, etc.)  with  the parasite.  Morphological studies  have 
already demonstrated the presence of structural changes in the integument of schis- 
tosomula during the early phase of their development (25, 26). It is unlikely that the 
formation of a  double  unit  membrane  is  involved  in  the  loss  of susceptibility  to 
immune damage because this second lipid bilayer is already present when the worms 
are still susceptible to immune attack (25). Recent freeze-fracture studies have revealed 
a  redistribution  of intramembranous  particles  along with  a  change  in  the  type of 
inclusion  body  in  the  integument  of maturing  worms,  which  occurs  during  the 
development of resistance to cytotoxic attack (27). However, a direct causal relation- 
ship between these changes in the ultrastructure of the schistosome membrane and 
the resistance of the parasite to damage has not been established. 
In addition to the integumental change discussed in this study, other processes have 
been described which probably contribute to the transition in susceptibility to immune 
damage undergone by developing schistosomula. Dean has argued that schistosomula 
cultured in vitro become resistant  to killing by antibody and C  because of a  loss in 
their antigenicity (i.e., reactivity with host antibody) which occurs independently of 
host  molecule  acquisition  (24).  That  schistosomula  do  indeed  spontaneously  and 
permanently  lose  their  surface  antigens  recognized  by  antischistosome  antibody 
during culture in chemically defined media has recently been confirmed by quanti- 
tative  immunofluorescence  (28).  Because either of these  changes  (i.e.,  an  intrinsic 
structural  change  in  the  integument  or  a  loss  in  surface  antigens)  in  itself could 
account for the resistance of lung worms to immune damage, the relevance of host 
molecule acquisition to the survival of the parasites is uncertain.  Nevertheless, it is 
possible that acquired host molecules (e.g., human A, B, H, and Lewis blood group 
antigens)  (29)  and mouse major histocompatibility complex gene products (11)  may 
play a protective role at a later (i.e., postlung) stage in the parasite's development, or 
may have some other immunoregulatory function. In this regard, it should be recalled 
that in the experiments of Smithers et al. (4), adult schistosomes recovered from mice 
were readily rejected when transferred to recipient monkeys immunized against mouse 
tissue, a finding which indicates that adult worms are indeed susceptible to immune 
damage  and  that  host  molecule  uptake  might  be  responsible  for  their  long-term 
survival during natural  infection. Thus,  it should be emphasized that  the findings 
presented here apply only to the antibody-dependent killing of schistosomula during 
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complement by schistosomula of Schistosoma mansoni. Exp.  Parasitol. In press. G.  MOSER,  D.  L.  WASSOM,  AND A. SHER  51 
the early stages of their development in the host. Recent evidence suggests that there 
may be additional killing mechanisms operating against later (i.e., postlung) devel- 
opmental stages of the parasite in mice immunized by chronic infections (1, 3). The 
factors governing the susceptibility of the parasite to this putative late mechanism of 
killing have not yet been eludicated. 
Finally, it should be noted that previous investigations of the killing ofschistosomula 
have employed heterogenous antibodies  directed  against  multiple antigens on  the 
parasite  surface.  As  a  result,  they  have  been  of limited  value  for  quantitatively 
analyzing the  specific  antigen-antibody interactions  involved  in  parasite  damage. 
This  difficulty can  now  be  overcome  by  the  use  of haptenated  schistosomula as 
described here. The approach may have general application for analyzing the immune 
killing of a variety of different parasite targets in addition to schistosomula. 
Summary 
A  method was  developed  for coupling  a  hapten,  trinitrophenyl  (TNP),  to  the 
surface of schistosomula of Schistosoma mansoni which results in a minimal loss in their 
viability as judged by morphological examination in vitro and survival after injection 
in vivo. Skin-stage (3-h-old)  and lung-stage (5-d-old) schistosomula surface labeled in 
this  manner  were  then  compared  for  their  susceptibility  to  killing  by  anti-TNP 
antibody-dependent effector mechanisms both in vivo and in vitro. TNP skin-stage 
larvae were readily rejected in mice actively immunized against TNP bovine gamma 
globulin and were highly susceptible to anti-TNP-dependent killing mediated either 
by complement or purified human eosinophils in vitro. In contrast, TNP-lung-stage 
schistosomula, which were shown by microfluorimetry to bind anti-TNP antibody to 
approximately the same extent as skin-stage schistosomula, were found to be resistant 
to killing by the same in vivo and in vitro mechanisms. These findings suggest that 
the  insusceptibility of postskin-stage  schistosomula  to  antibody-dependent  killing 
must result at least in part from an intrinsic structural change in the integument of 
the  parasite  and  cannot  be  caused  solely by  the  masking of parasite  antigens by 
acquired host molecules, a  mechanism of immune evasion previously proposed  for 
schistosomes. 
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